p16 Inactivation in small-sized lung adenocarcinoma: Its association with poor prognosis

International Journal of Cancer

Volumn 84, Issue 1, 1999, Pages 49-53

  Kawabuchi, Beniyo ^a   Moriyama, Sachiko ^b   Hironaka, Mitsugu ^a   Fujii, Takeshi ^a   Koike, Morio ^b   Moriyama, Hirokazu ^b   Nishimura, Yoshihiro ^b   Mizuno, Shoichi ^c   Fukayama, Masashi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCAR FORMATION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETINOBLASTOMA PROTEIN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032956084     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990219)84:1<49::AID-IJC10>3.0.CO;2-Y     Document Type: Article

References (20)

1. AUERBACH, O. and GARFINKEL, L., The changing pattern of lung carcinoma. Cancer, 68, 1973-1977 (1991).
2. DOSAKA-AKITA, H., HU, S.X., FUJINO, M., HARADA, M., KINOSHITA, I., XU, H.J., KUZUMAKI, N., KAWAKAMI, Y. and BENEDICT, W.F., Altered retinoblastoma protein expression in non-small cell lung cancer. Its synergistic effects with altered ras and p53 protein status on prognosis. Cancer, 79, 1329-1337 (1997).
3. GERADTS, J., KRATZKE, R.A., NIEHANS, G.A. and LINCOLN, C.E., Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res., 55, 6006-6011 (1995).
4. HAYASHI, Y., FUKAYAMA, M., KOIKE, M., KASEDA, S., IKEDA, T. and YOKOYAMA, T., Cell-cycle analysis detecting endogenous nuclear antigens: comparison with BrdU-in vivo labeling and an application to lung tumors. Acta Pathol. Jpn., 43, 313-319 (1993).
5. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S., III, JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
6. KRATZKE, R.A., GREATENS, T.M., RUBINS, J.B., MADDAUS, M.A., NIEWOEHNER, D.E., NIEHANS, G.A. and GERADTS, J., Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res., 56, 3415-3420 (1996).
7. KUROKAWA, T., MATSUNO, Y., NOGUCHI, M., MIZUNO, S. and SHIMOSATO, Y., Surgically curable "early" adenocarcinoma in the periphery of the lung. Amer. J. surg. Pathol., 18, 431-438 (1994).
8. LEE, J.S., YOON, A., KALAPURAKAL, S.K., RO, J.Y., LEE, J.J., TU, N., HITTELMAN, W.N. and HONG, W.K., Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor. J. clin. Oncol., 13, 1893-1903 (1995).
9. MARCHETTI, A., DOGLIONI, C., BARBARESCHI, M., BUTTITTA, F., PELLEGRINI, S., GAETA, P., LA ROCCA, R., MERLO, G., CHELLA, A., ANGELETTI, C.A., PALMA, P.D. and BEVILACQUA, G., Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. Int. J. Cancer, 75, 187-192 (1998).
10. NISHIO, M., KOSHIKAWA, T., KUROISHI, T., SUYAMA, M., UCHIDA, K., TAKAGI, Y., WASHIMI, O., SUGIURA, T., ARIYOSHI, Y., TAKAHASHI, T., UEDA, R. and TAKAHASHI, T., Prognostic significance of abnormal p53 accumulation in primary, resected non-small cell lung cancers. J. clin. Oncol., 14, 497-502 (1996).
11. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
12. OKAMOTO, A., DEMETRICK, D.J., SPILLARE, E.A., HAGIWARA, K., HUSSAIN, S.P., BENNETT, W.P., FORRESTER, K., GERWIN, B., SERRANO, M., BEACH, D.H. and HARRIS, C.C., Mutations and altered expression of p16INK4 in human cancer. Proc. nat. Acad. Sci. (Wash.), 91, 11045-11049 (1994).
13. SAKAGUCHI, M., FUJII, Y., HIRABAYASHI, H., YOON, H.E., KOMOTO, Y., OUE, T., KUSAFUKA, T., OKADA, A. and MATSUDA, H., Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int. J. Cancer, 65, 442-445 (1996).
14. SHAPIRO, G.I., EDWARDS, C.D., KOBZIK, L., GODLESKI, J., RICHARDS, W., SUGARBAKER, D.J. and ROLLINS, B.J., Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res., 55, 505-509 (1995).
15. SHAPIRO, G.I. and ROLLINS, B.J., p16INK4A as a human tumor suppressor. Biochem. biophys. Acta, 1242, 165-169 (1996).
16. SHIMOSATO, Y., HASHIMOTO, T., KODAMA, T., KAMEYA, T., SUZUKI, A., NISHIWAKI, Y. and YONEYAMA, T., Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Amer. J. surg. Pathol., 4, 365-373 (1980).
17. TAGA, S., OSAKI, T., OHGAMI, A., IMOTO, H., YOSHIMATSU, T., YOSHINO, I., YANO, K., NAKANISHI, R., ICHIYOSHI, Y. and YASUMOTO, K., Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma. Cancer, 80, 389-395 (1997).
18. TAKISE, A., KODAMA, T., SHIMOSATO, Y., WATANABE, S. and SUEMASU, K., Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer, 61, 2083-2088 (1988).
19. TSUGANE, S., WATANABE, S., SUGIMURA, H., URANO, Y. and MATSUBARA, S., Recent trends in different histological types of lung cancer in Tokyo based on pathological autopsy records. Jpn. J. Cancer. Res., 78, 162-169 (1987).
20. XU, H.J., QUINLAN, D.C., DAVIDSON, A.G., HU, S.X., SUMMERS, C.L., LI, J. and BENEDICT, W.F., Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J. nat. Cancer Inst., 86, 695-699 (1994).